IDEXX Laboratories, Inc. (IDXX) Shares Outstanding: 0.08
Is IDEXX Laboratories, Inc.’s shares outstanding high or low?
IDEXX Laboratories, Inc.'s shares outstanding of 0.08 is in line with its 5-year average of 0.08, near the low end of its 5-year range (0.08–0.09).
The shares outstanding for IDEXX Laboratories, Inc. (IDXX) is 0.08. It is below its 12-month average by 1.46% (0.08).
IDXX Shares Outstanding Chart
IDXX Average Shares Outstanding Chart
IDXX Current vs Average Shares Outstanding Chart
IDXX Shares Outstanding Metrics
SHARES OUTSTANDING
0.08
SHARES OUTSTANDING AVG TTM
0.08
SHARES OUTSTANDING AVG 3Y
0.08
SHARES OUTSTANDING AVG 5Y
0.08
SHARES OUTSTANDING AVG 10Y
0.09
SHARES OUTSTANDING AVG 15Y
0.09
SHARES OUTSTANDING AVG 20Y
0.10
CURRENT VS TTM AVG
-1.46%
CURRENT VS 3Y AVG
-2.69%
CURRENT VS 5Y AVG
-3.85%
CURRENT VS 10Y AVG
-6.56%
CURRENT VS 15Y AVG
-13.89%
CURRENT VS 20Y AVG
-20.08%
Share Structure
Shares Outstanding
80.10M
Float Shares
N/A
Stock Price
$578.89
Market Cap
$45.7B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 80.10M | -2.88% |
| 2024 | 82.47M | -0.72% |
| 2023 | 83.07M | -0.67% |
| 2022 | 83.62M | -1.85% |
| 2021 | 85.20M | -0.17% |
| 2020 | 85.34M | -0.90% |
| 2019 | 86.11M | -0.86% |
| 2018 | 86.86M | -1.03% |
| 2017 | 87.77M | -2.19% |
| 2016 | 89.73M | -3.10% |
| 2015 | 92.60M | -7.49% |
| 2014 | 100.09M | -5.85% |
| 2013 | 106.32M | -3.32% |
| 2012 | 109.97M | -3.18% |
| 2011 | 113.58M | -1.60% |
| 2010 | 115.43M | -1.86% |
| 2009 | 117.62M | -1.91% |
| 2008 | 119.91M | -2.61% |
| 2007 | 123.12M | -2.08% |
| 2006 | 125.73M | -3.35% |
| 2005 | 130.08M | -4.95% |
| 2004 | 136.86M | -0.17% |
| 2003 | 137.08M | +1.93% |
| 2002 | 134.49M | +0.99% |
| 2001 | 133.17M | -3.71% |
| 2000 | 138.30M | -9.85% |
| 1999 | 153.41M | +0.93% |
| 1998 | 152.00M | +0.85% |
| 1997 | 150.71M | +1.71% |
| 1996 | 148.18M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
IDEXX Laboratories, Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. Shares Outstanding FAQ
- What is the shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The shares outstanding for IDXX stock is 0.08.
- Is IDEXX Laboratories, Inc.'s shares outstanding high or low?
- IDEXX Laboratories, Inc.'s shares outstanding of 0.08 is in line with its 5-year average of 0.08, near the low end of its 5-year range (0.08–0.09).
- What is the TTM average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The TTM average shares outstanding for IDXX stock is 0.08.
- What is the 3Y average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The 3Y average shares outstanding for IDXX stock is 0.08.
- What is the 5Y average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The 5Y average shares outstanding for IDXX stock is 0.08.
- What is the 10Y average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The 10Y average shares outstanding for IDXX stock is 0.09.
- What is the 15Y average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The 15Y average shares outstanding for IDXX stock is 0.09.
- What is the 20Y average shares outstanding for IDEXX Laboratories, Inc. (IDXX)?
- The 20Y average shares outstanding for IDXX stock is 0.10.
IDEXX Laboratories, Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 0.08 |
| 2024-12-31 | 0.08 |
| 2023-12-31 | 0.08 |
| 2022-12-31 | 0.08 |
| 2021-12-31 | 0.09 |
| 2020-12-31 | 0.09 |
| 2019-12-31 | 0.09 |
| 2018-12-31 | 0.09 |
| 2017-12-31 | 0.09 |
| 2016-12-31 | 0.09 |
| 2015-12-31 | 0.09 |
| 2014-12-31 | 0.10 |
| 2013-12-31 | 0.11 |
| 2012-12-31 | 0.11 |
| 2011-12-31 | 0.11 |
| 2010-12-31 | 0.12 |
| 2009-12-31 | 0.12 |
| 2008-12-31 | 0.12 |
| 2007-12-31 | 0.12 |
| 2006-12-31 | 0.13 |
| 2005-12-31 | 0.13 |
| 2004-12-31 | 0.14 |
| 2003-12-31 | 0.14 |
| 2002-12-31 | 0.13 |
| 2001-12-31 | 0.13 |
| 2000-12-31 | 0.14 |
| 1999-12-31 | 0.15 |
| 1998-12-31 | 0.15 |
| 1997-12-31 | 0.15 |
| 1996-12-31 | 0.15 |
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky